Nicos Karasavvas
Bangkok, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Differential Genome Replication of a Unique Single-Amino-Acid Mutation in the Adenovirus-4 Component of the Live Oral Adenovirus Type 4 and Type 7 Vaccine.
Journal: Vaccines
Published: May 12, 2023
A Phase 1 Two-Arm, Randomized, Double-Blind, Active-Controlled Study of Live, Oral Plasmid-Derived Adenovirus Type 4 and Type 7 Vaccines in Seronegative Adults.
Journal: Vaccines
Published: May 12, 2023
Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall response.
Journal: PLoS pathogens
Published: November 30, 2022
Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates.
Journal: Nature
Published: June 29, 2022
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 02, 2021
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
Journal: bioRxiv : the preprint server for biology
Published: April 14, 2021
Complete Genome Sequences of Two Human Adenovirus Type 55 Isolates from South Korea and the United States.
Journal: Microbiology resource announcements
Published: February 05, 2021
Live Oral Adenovirus Type 4 and Type 7 Vaccine Induces Durable Antibody Response.
Journal: Vaccines
Published: June 01, 2020
Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trial.
Journal: The lancet. HIV
Published: June 04, 2019
Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations.
Journal: PloS one
Published: January 04, 2018
Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens.
Journal: AIDS research and human retroviruses
Published: December 23, 2016
Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial.
Journal: The Journal of infectious diseases
Published: October 11, 2016
Last Updated: 09/26/2026